Newsroom

TEMPE, Ariz.--(BUSINESS WIRE)--First Solar, Inc. (Nasdaq: FSLR) (the “Company”) today announced financial results for the second quarter ended June 30, 2025, and updated its 2025 guidance. Net sales for the second quarter were $1.1 billion, an increase of $0.3 billion from the prior quarter. The increase in net sales was primarily due to an increase in the volume of modules sold to third parties. During the quarter, the Company sold $312 million of Section 45X tax credits generated during 2025...

CHICAGO--(BUSINESS WIRE)--Global professional services firm Huron (NASDAQ: HURN) today announced the successful refinancing and expansion of its senior secured credit facility. Among other items, the amended and restated credit facility: Extends the maturity date from November 2027 to July 2030 Increases borrowing capacity to $1.1 billion, consisting of a $700 million Revolving Credit Facility and $400 million Term Loan A Improves pricing and flexibility to enable Huron’s balanced approach to c...

SAN MATEO, Calif.--(BUSINESS WIRE)--Backblaze, Inc. (Nasdaq: BLZE), the cloud storage innovator providing a modern alternative to traditional cloud providers, continues their push to provide enterprises with better cloud storage infrastructure options for AI workflows by being a Gold-level sponsor at Ai4 2025 in Las Vegas August 11–13. Backblaze recently launched B2 Overdrive, a highly performant cloud storage solution that provides up to 1Tbps throughput speeds, allowing enterprises to perform...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aeva® (NASDAQ: AEVA), a leader in next-generation sensing and perception systems, today hosted Aeva Day: Beyond the Beam in New York City, where the company showcased how its unique perception platform can enable the future of sensing and perception across multiple applications and industries at mass scale. At the event, key customers, partners and industry leaders shared their insights on Aeva’s differentiated performance and the growing trend towards FM...

PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced the appointment of Raymond J. Deshaies, Ph.D., to its board of directors. Dr. Deshaies is a pioneering biochemist and cell biologist with more than 25 years of experience in biotechnology and drug development. He recently served as senior vice president of global research at Amgen Inc., whe...

SAN JOSE, Calif.--(BUSINESS WIRE)--After market close on August 27, 2025, NetApp (NASDAQ: NTAP) will announce financial results for the first quarter of fiscal year 2026, which ended July 25, 2025. NetApp executive management will host a conference call Webcast at 2:30 p.m. Pacific Time to discuss these results and provide their perspective on market dynamics. How to Participate The live Webcast call can be accessed at investors.netapp.com. Please allow at least 15 minutes prior to the start of...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Perdoceo Education Corporation Reports Second Quarter and Year to Date 2025 Results...

SEATTLE--(BUSINESS WIRE)--Amazon.com, Inc. (NASDAQ: AMZN) today announced financial results for its second quarter ended June 30, 2025. Net sales increased 13% to $167.7 billion in the second quarter, compared with $148.0 billion in second quarter 2024. Excluding the $1.5 billion favorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 12% compared with second quarter 2024. North America segment sales increased 11% year-over-year to $100...

LAS VEGAS--(BUSINESS WIRE)--Rimini Street, Inc., (the “Company”) (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced results for the fiscal second quarter ended June 30, 2025. Select Second Quarter 2025 Financial Results Revenue was $104.1 million for the 2025 second quarter, an increase of 1.0% compared to $103.1 million for the same period last ye...

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced its second quarter 2025 financial results and provided an update on business highlights. “We continue making significant progress across all three of our pivotal Phase 3 trials evaluating MM120 ODT in GAD and MDD, with ongoing enthusiasm from both trial sites and...